BioXcel to seek approval for at-home use of agitation drug after upbeat study – Reuters
- BioXcel to seek approval for at-home use of agitation drug after upbeat study Reuters
- BioXcel’s agitation drug meets main goal in at-home study MarketScreener
- BioXcel Therapeutics Reports Successful Results from SERENITY At-Home Trial for BXCL501 as At-Home Treatment for Agitation in Bipolar Disorders and Schizophrenia Quiver Quantitative
- BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later Stocktwits
- BioXcel to seek label update for psych drug after Phase 3 success Endpoints News